1/5
FIEO Registered FIEO Registered Export Ready

Ranitidine Injection 50mg/2ml

Sold by ancalima lifesciences limited · Manufacturer, Exporter · Murthal, Haryana, India

Price
Price on request
In stock
Minimum order: 1 unit

Export Snapshot

MOQ
1 unit
Lead time
On request
Packaging
Tray pack of 10 ampoules
Shelf life / longevity
Store below 25°C, protect from light
HS Code
On request
Origin
India
Port of dispatch
On request
Export markets served
Bangladesh flag BD Cameroon flag CM Dominican Republic flag DO Honduras flag HN India flag IN +3 others
Values shown are for ancalima lifesciences limited.
Compliance & Certifications
ISO 9001:2015
Suitable for

Importers · Distributors · Wholesalers

Know your supplier

ancalima lifesciences limited is a Manufacturer, Exporter based in Murthal Haryana India.

Murthal Dispatch on request FIEO member
ancalima lifesciences limited logo

Manufacturer, Exporter · Murthal, Haryana, India

Ancalima is manufacturer & exporter of Cosmetic & Pharmaceutical Formulations.

Registered address: Sonipat, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals > Drugs & Pharmaceuticals.

Established
1970
Employees
11–30
GST
06AACCP5005B1Z4
IEC code
3395003396
Export markets
Bangladesh flag BD Cameroon flag CM Dominican Republic flag DO Honduras flag HN India flag IN +3 others
GlobalLinker Member Since
May 2021
Turnover
2500001 - 10000000.
Incorporation Type
On request
Product details

What are the specifications of this product?

Overview

Ranitidine InjectionRanitidine Injection is a biocompatible injectable formulation for targeted H2 receptor antagonism, facilitating gastric acid suppression in acute clinical applications.The 50mg/2ml volume provides a standardized dose, enabling precise administration and predictable therapeutic efficacy.Key Features:Optimized aqueous injectable for rapid absorption50mg active concentration per 2ml unitPhysicochemical stability ensures reproducible clinical effectRegulated for professional institutional useAttributes:50mg/2ml for accurate dosingInjectable formulation with controlled flow characteristicsCompliance with pharmaceutical quality standards

Product Description

Composition and Formulation Details

Ranitidine Injection contains pharmaceutically pure Ranitidine Hydrochloride in sterile isotonic aqueous medium. Buffering agents maintain pH stability and prevent degradation, while excipients ensure solubility and homogeneity for reliable parenteral administration.

Functional Characteristics and Performance

The injection provides consistent bioavailability and rapid onset of action. Its optimized viscosity facilitates smooth intravenous or intramuscular administration with minimal discomfort. Stability under ambient and refrigerated conditions ensures predictable pharmacodynamics for professional clinical use.

Application and Industry Relevance

Ranitidine Injection is widely used in hospital pharmacies, emergency care units, and institutional procurement channels. Its bulk sourcing, OEM supply, and export-ready packaging align with regulated pharmaceutical markets, supporting professional B2B buyers seeking reliable acid-suppressive injectable therapy.

Description provided by ancalima lifesciences limited.

Specifications

Active Ingredient Ranitidine Hydrochloride
Strength 50mg/2ml
Dosage Form Injection (Solution)
Pharmacopeia Compliance British Pharmacopoeia (BP)
Therapeutic Class H2 Blockers
Packaging Tray pack of 10 ampoules
Ampoule Volume 2ml
Administration Route IV/IM Injection
Sterility Sterile
Storage Condition Store below 25°C, protect from light

Use cases

Category Pharmaceuticals > Injections > H2 Blockers Injection
Primary application Wholesale, distribution, and international sourcing
Brand Not specified
Product type Product

Logistics & handling

Lead time On request
Packaging Tray pack of 10 ampoules
Storage condition Store below 25°C, protect from light
Origin India
Form As listed by supplier

Commercials (this seller)

Minimum order 1 unit
Lead time On request
Payment terms As per negotiated commercial agreement.
Checkout type enquiry
Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing Ranitidine Injection 50mg/2ml. Answers compiled from verified sellers' commercial terms and platform data.

Q: Is the Ranitidine Injection compliant with international pharmacopeia standards?
A: Yes, the Ranitidine Injection 50mg/2ml is manufactured in compliance with the British Pharmacopoeia (BP) standards ensuring quality and safety.
Q: What is the recommended route of administration for this Ranitidine Injection?
A: This injection is intended for intravenous (IV) or intramuscular (IM) administration as per clinical guidelines.
Q: How is Ranitidine Injection packaged for bulk hospital usage?
A: It is supplied as a tray pack containing 10 sterile 2ml ampoules, facilitating ease of use and storage in healthcare settings.
Q: What is the main therapeutic use of Ranitidine Injection 50mg/2ml?
A: It is primarily used for treating conditions associated with excessive gastric acid secretion, such as ulcers and GERD, especially when oral medication is not feasible.
Q: What precautions are recommended for storage of Ranitidine Injection ampoules?
A: The injection should be stored below 25°C and protected from direct light to preserve its potency.
Question not answered? Ask sellers directly — typical response within 4 hours.
Ranitidine Injection 50mg/2ml
Ranitidine Injection 50mg/2ml
Price on request · MOQ 1unit